# MediSix Therapeutics, Inc. — Form D/A

MediSix Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2023-08-04. The offering totals $22.5M, of which $22.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-08-04
- Form: D/A
- Accession: 0001790058-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $22.5M
- Investors: 5
- Date of first sale: 2021-04-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-395539

## Issuer

- Name: MediSix Therapeutics, Inc.
- CIK: 0001790058
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 500 BOYLSTON STREET, SUITE 1380, BOSTON, MA, 02116
- Phone: 617-933-3770

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Andrew R Bruce | Director | BOSTON, MA |
| MICHAEL CARUSI | Director | San Clemente, CA |
| William A Harrington | Director | BOSTON, MA |
| George A Poste | Director | BOSTON, MA |
| Andrew R Bruce | Executive Officer | BOSTON, MA |
| Michael A Carusi | Director | Menlo Park, CA |
| Kenneth D Noonan | Director | BOSTON, MA |
| Kenneth D Noonan | Executive Officer | BOSTON, MA |
| Michael D Carusi | Director | BOSTON, MA |
| George H Poste | Director | Singapore, U0 |
| Sarah D Lim | Executive Officer | Singapore, U0 |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-04-13](https://search.stillhousedata.com/formd/0001713695-21-000001) | D | $22.0M | $15.0M |
| [2019-10-02](https://search.stillhousedata.com/formd/0001790058-19-000001) | D | $20.4M | $20.4M |

## More

- [CIK 1790058 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1790058&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001790058-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.